Phase I/II Trial of Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 31 Jan 2019
At a glance
- Drugs Avelumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Large cell carcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2019 Trial design presented at the 2019 Gastrointestinal Cancers Symposium
- 16 Jan 2019 Status changed from suspended to recruiting.
- 05 Oct 2018 Status changed from recruiting to suspended.